Back
Editas Medicine, Inc. Vs. Rapt Therapeutics, Inc. Industry Stock Comparison
Sell
36
EDIT
Editas Medicine, Inc.
Last Price:
$2.52
Seasonality Move:
-5.13%
Sell
44
RAPT
Rapt Therapeutics, Inc.
Last Price:
$34.00
Seasonality Move:
-10.23%
Sell
36
Editas Medicine, Inc. (EDIT)
is a Sell
Is Editas Medicine, Inc. a Buy, Sell or Hold?
-
The current Editas Medicine, Inc. [EDIT] share price is $2.51. The Score for EDIT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
EDIT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Rapt Therapeutics, Inc. (RAPT)
is a Sell
Is Rapt Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Rapt Therapeutics, Inc. [RAPT] share price is $34.03. The Score for RAPT is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
RAPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EDIT Stock Price Chart
What is Editas Medicine, Inc.'s stock price today?
-
The Editas Medicine, Inc. share price today is $2.51Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EDIT is experiencing slight selling pressure.
RAPT Stock Price Chart
What is Rapt Therapeutics, Inc.'s stock price today?
-
The Rapt Therapeutics, Inc. share price today is $34.03The current trend is moderately bullish and RAPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
EDIT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 47.22 | Sell |
| Chaikin Money Flow: | 84316 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.34 - 2.6) | Buy |
| Bollinger Bands (100): | (2.37 - 3.41) | Sell |
RAPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.66 | Buy |
| Relative Strength Index (14 RSI): | 55.95 | Buy |
| Chaikin Money Flow: | 205819 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.63 - 34.75) | Buy |
| Bollinger Bands (100): | (14.04 - 31.9) | Buy |
EDIT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.49 | Buy |
| 20-day SMA: | 2.44 | Buy |
| 50-day SMA: | 2.95 | Sell |
| 200-day SMA: | 2.36 | Buy |
| 8-day EMA: | 2.48 | Buy |
| 20-day EMA: | 2.5 | Buy |
| 50-day EMA: | 2.4 | Buy |
| 200-day EMA: | 1.22 | Buy |
RAPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.08 | Sell |
| 20-day SMA: | 32.41 | Buy |
| 50-day SMA: | 30.48 | Buy |
| 200-day SMA: | 15.73 | Buy |
| 8-day EMA: | 34.48 | Sell |
| 20-day EMA: | 33.02 | Buy |
| 50-day EMA: | 29.7 | Buy |
| 200-day EMA: | 21.78 | Buy |
Editas Medicine, Inc. Earnings Growth & EDIT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.69 per share, and an increase next year of $0.89 per share.
Rapt Therapeutics, Inc. Earnings Growth & RAPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $12.75 per share, and a decrease next year of $0.91 per share.
Editas Medicine, Inc. Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rapt Therapeutics, Inc. Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||